Pharma giant GSK surged to the top of the index as it missed forecasts slightly with its annual results, but raised its ...

London stocks nudged higher in early trade on Wednesday as investors mulled disappointing US tech results and continued to ...

GSK (LON: GSK) has issued an update which inevitably reflects the difficulties faced in the last year, while also providing a host of reasons to be more upbeat on future prospects. Concerns over the ...

The report provides insights into GSK's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) ...

The Motley Fool UK has recommended GSK. Views expressed on the companies ... We publish information, opinion and commentary about consumer credit products, loans, mortgages, insurance, savings ...

Zacks Equity Research shares Kratos Defense & Security Solutions KTOS as the Bull of the Day and GSK PLC GSK as the Bear of ...

while GSK was a standout performer in early trade. The FTSE 100 index fell 6.52 points, 0.1%, at 8,564.25. The FTSE 250 declined 60.33 points, 0.3%, at 20,592.93. The AIM All-Share fell 0.80 of a ...

The deal includes two recently approved GSK products for metastatic melanoma ... lucrative and growing sectors in the industry. The UK-headquartered firm says this part of the deal represents ...

Nicotine Gums and Mints market to Witness Substantial Growth Amid Rising Demand for Smoking Cessation Products Ankush Nikam Future Market Insights, Inc. + +91 90966 84197 email us here Visit us on ...

GSK’s lead in vaccines is a cause for concern after mixed political signals in the US, with ardent vaccine sceptic Robert F Kennedy Jr vowing a clampdown on the pharmaceutical industry, which partly ...

Astex Pharmaceuticals has been celebrating a very successful first 25 years following a visit from Science minister Patrick ...